← Home
Lancet Neurol · Jan 2020
Read original source →

Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial

Extended follow-up of ARUBA; the benchmark for outcomes of intervention against medical management.

Open at Lancet Neurol ↗
Index entry — verify clinical detail against the primary source.
Related conditions
unruptured-brain-avm

For learning and professional reference; not a patient-specific recommendation. How we prepare content.